Cargando…

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes

BACKGROUND: The multi-arm multi-stage (MAMS) design described by Royston et al. [Stat Med. 2003;22(14):2239–56 and Trials. 2011;12:81] can accelerate treatment evaluation by comparing multiple treatments with a control in a single trial and stopping recruitment to arms not showing sufficient promise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bratton, Daniel J., Parmar, Mahesh K. B., Phillips, Patrick P. J., Choodari-Oskooei, Babak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930581/ https://www.ncbi.nlm.nih.gov/pubmed/27369182 http://dx.doi.org/10.1186/s13063-016-1382-5

Ejemplares similares

Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
por: Blenkinsop, Alexandra, et al.
Publicado: (2019)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Adding new experimental arms to randomised clinical trials: Impact on error rates
por: Choodari-Oskooei, Babak, et al.
Publicado: (2020)

Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial
por: Choodari-Oskooei, Babak, et al.
Publicado: (2023)

A multi-arm multi-stage design for binary outcomes and application to tuberculosis
por: Bratton, Daniel, et al.
Publicado: (2013)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Combined test versus logrank/Cox test in 50 randomised trials
por: Royston, Patrick, et al.
Publicado: (2019)

A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis
por: Bratton, Daniel J, et al.
Publicado: (2013)

Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently
por: White, Ian R, et al.
Publicado: (2022)

How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design – a reanalysis of 4 trials
por: Barthel, FM-S, et al.
Publicado: (2009)

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
por: Sydes, Matthew R, et al.
Publicado: (2009)

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2012)

A new measure of predictive ability for survival models
por: Choodari-Oskooei, Babak, et al.
Publicado: (2011)

The extension of total gain (TG) statistic in survival models: properties and applications
por: Choodari-Oskooei, Babak, et al.
Publicado: (2015)

RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse
por: Oza, Bhavna, et al.
Publicado: (2021)

Measuring the impact of methodological research: a framework and methods to identify evidence of impact
por: Brueton, Valerie C, et al.
Publicado: (2014)

Familywise error control in multi‐armed response‐adaptive trials
por: Robertson, D. S., et al.
Publicado: (2019)

Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit
por: Royston, Patrick, et al.
Publicado: (2011)

Bayesian adaptive designs for multi-arm trials: an orthopaedic case study
por: Ryan, Elizabeth G., et al.
Publicado: (2020)

The need for a cultural shift from two-arm to multi-arm RCTS
por: Sydes, Matthew R, et al.
Publicado: (2013)

Power for tests of interaction: effect of raising the Type I error rate
por: Marshall, Stephen W
Publicado: (2007)

Controlling type I error rates in multi-arm clinical trials: A case for the false discovery rate
por: Wason, James M. S., et al.
Publicado: (2021)

Point estimation for adaptive trial designs I: A methodological review
por: Robertson, David S., et al.
Publicado: (2022)

Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design
por: Richert, Laura, et al.
Publicado: (2014)

Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings
por: Noor, Nurulamin M., et al.
Publicado: (2020)

Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform
por: Gilson, C., et al.
Publicado: (2017)

Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial
por: Sydes, Matthew R, et al.
Publicado: (2011)

Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer
por: Zeissler, Marie-Louise, et al.
Publicado: (2020)

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
por: Foltynie, Tom, et al.
Publicado: (2023)

Impact of genotyping errors on the type I error rate and the power of haplotype-based association methods
por: Marquard, Vivien, et al.
Publicado: (2009)

Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials
por: Noor, Nurulamin M, et al.
Publicado: (2022)

Modifying the multi-arm multi-stage (MAMS) design for use in a phase II tuberculosis trial in sub-Saharan Africa with a time-to-event primary outcome
por: Phillips, Patrick, et al.
Publicado: (2013)

Some recommendations for multi-arm multi-stage trials
por: Wason, James, et al.
Publicado: (2012)

Type I Error Control for Tree Classification
por: Jung, Sin-Ho, et al.
Publicado: (2014)

Review and evaluation of performance measures for survival prediction models in external validation settings
por: Rahman, M. Shafiqur, et al.
Publicado: (2017)

Fostering emotional, social, physical and educational wellbeing in rural India: the methods of a multi-arm randomized controlled trial of Girls First
por: Leventhal, Katherine Sachs, et al.
Publicado: (2015)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Treatment selection in multi-arm, multi-stage clinical trials
por: Jaki, Thomas, et al.
Publicado: (2013)

A response‐adaptive randomization procedure for multi‐armed clinical trials with normally distributed outcomes
por: Williamson, S. Faye, et al.
Publicado: (2019)

Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate
por: Morris, Tim P, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kotvdmfj6582j16ef40mra790u